Announcements

4 March 2026
MDPI’s 2025 Best Paper Awards—Award-Winning Papers Announced


MDPI is honored to announce the recipients of the 2025 Best Paper Awards, celebrating exceptional research for its scientific merit and broad impact. After a rigorous evaluation process conducted by Academic Editors, this year’s awards showcase papers that stand out for their innovation, relevance, and high-quality presentation.

Out of a highly competitive pool, 396 winning papers have been recognized for their exceptional contributions. We congratulate these authors for pushing the boundaries of their respective disciplines.

At MDPI, we are dedicated to broadening the reach of innovative science. To learn more about the award-winning papers and explore research projects in your field of study, please visit the following links:

About MDPI Awards:

To reward the global research community and enhance academic dialogue, MDPI journals regularly host award programs across diverse scientific disciplines. These awards, serving as a source of inspiration and recognition, help raise the influence of talented individuals who have been credited with outstanding achievements and whose work drives the advancement of their fields.

Explore the Best Paper Awards open for participation, please click here.

 

6 November 2025
MDPI Launches the Michele Parrinello Award for Pioneering Contributions in Computational Physical Science


MDPI is delighted to announce the establishment of the Michele Parrinello Award. Named in honor of Professor Michele Parrinello, the award celebrates his exceptional contributions and his profound impact on the field of computational physical science research.

The award will be presented biennially to distinguished scientists who have made outstanding achievements and contributions in the field of computational physical science—spanning physics, chemistry, and materials science.


About Professor Michele Parrinello

"Do not be afraid of new things. I see it many times when we discuss a new thing that young people are scared to go against the mainstream a little bit, thinking what is going to happen to me and so on. Be confident that what you do is meaningful, and do not be afraid, do not listen too much to what other people have to say.”

——Professor Michele Parrinello

Born in Messina in 1945, he received his degree from the University of Bologna and is currently affiliated with the Italian Institute of Technology. Professor Parrinello is known for his many technical innovations in the field of atomistic simulations and for a wealth of interdisciplinary applications ranging from materials science to chemistry and biology. Together with Roberto Car, he introduced ab initio molecular dynamics, also known as the Car–Parrinello method, marking the beginning of a new era both in the area of electronic structure calculations and in molecular dynamics simulations. He is also known for the Parrinello–Rahman method, which allows crystalline phase transitions to be studied by molecular dynamics. More recently, he has introduced metadynamics for the study of rare events and the calculation of free energies.

For his work, he has been awarded many prizes and honorary degrees. He is a member of numerous academies and learned societies, including the German Berlin-Brandenburgische Akademie der Wissenschaften, the British Royal Society, and the Italian Accademia Nazionale dei Lincei, which is the major academy in his home country of Italy.


Award Committee

The award committee will be chaired by Professor Xin-Gao Gong, a computational condensed matter physicist, academician of the Chinese Academy of Sciences, and professor at the Department of Physics, Fudan University. Professor Xin-Gao Gong will lead a panel of several senior experts in the field to oversee the evaluation and selection process.

The Institute for Computational Physical Sciences at Fudan University (Shanghai, China), led by Professor Xin-Gao Gong, will serve as the supporting institute for the award.

"We hope the Michele Parrinello Award will recognize scientists who have made significant contributions to the field of computational condensed matter physics and at the same time set a benchmark for the younger generation, providing clear direction for their pursuit—this is precisely the original intention behind establishing the award."

——Professor Xin-Gao Gong

The first edition of the award was officially launched on 1 November 2025. Nominations will be accepted before the end of March 2026. For further details, please visit mparrinelloaward.org.


About the MDPI Sustainability Foundation and MDPI Awards

The Michele Parrinello Award is part of the MDPI Sustainability Foundation, which is dedicated to advancing sustainable development through scientific progress and global collaboration. The foundation also oversees the World Sustainability Award, the Emerging Sustainability Leader Award, and the Tu Youyou Award. The establishment of the Michele Parrinello Award will further enrich the existing award portfolio, providing continued and diversified financial support to outstanding professionals across various fields. 

In addition to these foundation-level awards, MDPI journals also recognize outstanding contributions through a range of honors, including Best Paper Awards, Outstanding Reviewer Awards, Young Investigator Awards, Travel Awards, Best PhD Thesis Awards, Editor of Distinction Awards, and others. These initiatives aim to recognize excellence across disciplines and career stages, contributing to the long-term vitality and sustainability of scientific research.

Find more information on awards here.

16 March 2026
Welcoming New Editorial Board Members of Current Oncology

We are pleased to announce that four new scholars have been appointed as Editorial Board Members (EBMs) of Current Oncology (ISSN: 1718-7729). We wish our new member success in both their research and their efforts to develop the journal.

Name: Dr. Sébastien Perreault
Affiliation: Division of Child Neurology, CHU Sainte-Justine, Montréal, QC H3T 1C5, Canada
Interests: pediatric neuro-oncology; low-grade gliomas; targeted therapy; clinical trials
Section: “Neuro-Oncology”

Name: Dr. Toshinari Yamashita
Affiliation: Department of Breast Surgery and Oncology, Kanagawa Cancer Center, Yokohama, Japan
Interests: breast cancer; clinical research; translational research
Section: “Breast Cancer”

Name: Dr. Olav F. Dajani
Affiliation: Department of Oncology, Oslo University Hospital, 0424 Oslo, Norway
Interests: pancreatic cancer; hepatobilary cancer; phase II/III trials; symptom management; cancer cachexia; patient-reported outcomes; trials; palliative care; cancer; patient-centred care; patient pathway; symptom control; implementation science; integration; process evaluation; phase II/III; oncology; critical success factors; implementation; caregivers
Section: “Palliative and Supportive Care”

Name: Prof. Dickran Kazandjian
Affiliation: Myeloma Division, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA
Interests: multiple myeloma; MGUS; smoldering myeloma; immunotherapy; drug development; minimal residual disease
Section: “Hematology”

Further details about the Editorial Board of Current Oncology can be found by clicking the following link: https://www.mdpi.com/journal/curroncol/editors.

28 February 2026
MDPI INSIGHTS: The CEO’s Letter #32 - MDPI China and Thailand, China Science Daily, 1,000 Partnerships, R2R

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflections from China: Year-End-Celebrations and Open Access Publishing

In February, I had the pleasure of joining over a thousand colleagues from our Tongzhou and Haidian offices at their end-of-year annual celebration in Beijing.

Spending time with our teams in China is also a powerful reminder of the scale and complexity of MDPI as a global organization. Our colleagues in Beijing, Wuhan, and across the country play a significant role in our day-to-day operations and long-term development. I’m grateful for the hospitality, collaboration, and commitment shown by our managers and teams in China, alongside colleagues worldwide, who have helped steadily build MDPI, brick by brick, over the years.

Below are some data on Open Access (OA) publishing in China and our collaboration in this important research market.

Open Access Publishing in China

China has been the world’s leading country in research and review article publication volume since 2019, exceeding one million publications in 2025. Over the past five years, the gap between China and the second-ranked country, the United States, has continued to widen.

In 2025:

  • 47% of China’s research output was published Open Access
  • Of those OA publications, 76% were Gold Open Access (approximately 382,930 articles)
  • The overall OA distribution remained stable compared with 2024, with Gold OA increasing by 1%

Over the past five years (2021–2025):

  • China published 4,398,050 research and review articles
  • Approximately 48% of this output was OA

According to Dimensions, when comparing the top 20 countries by publication volume (2021–2025):

  • China ranks 1st worldwide in publication volume
  • China ranks 9th in citation performance within this group (for comparison, the US ranks 2nd in publication volume and 10th in citation ranking)
  • Average citations per article: 12.51

Among the top 10 universities globally by publication volume, six are Chinese institutions, alongside Harvard University (USA), the University of São Paulo (Brazil), the University of Toronto (Canada), and the University of Oxford (UK).

MDPI and China

China is an important and long-standing part of MDPI’s global publishing ecosystem:

  • In 2025, MDPI was the largest fully Open Access publisher in China
  • MDPI published 22% of China’s Gold Open Access output (82,133 papers)
  • We received 290,999 submissions from China-affiliated authors and published 82,133 articles
  • There are 8,500+ active Editorial Board Members based in China
    • 64% (5,438) have an H-index above 26
  • MDPI works with:
    • 117 Editors-in-Chief
    • 103 Section Editors-in-Chief
  • 71 China-based institutions currently hold IOAP agreements with MDPI, seven of which rank among the top 10 Chinese institutions by publication volume

China's scale in research output means that the publishing platforms chosen by Chinese scholars will continue to influence the direction of scholarly publishing. At the same time, MDPI’s strength comes from its international collaboration, with colleagues, editors, reviewers, and authors working together across regions and disciplines.

Thank you to all our colleagues in China, and around the world, who support MDPI’s publishing activities across departments and help advance open access research every day.

Impactful Research

“Progress in open science is built through trust, dialogue, and relationships”

Behind the Scenes: A Conversation with China Science Daily

During my trip to Beijing, I also had the opportunity to visit China Science Daily and take part in an interview and broader exchange with their team in Beijing. Visits like this matter because progress in open science is built not only through platforms and infrastructure, but also through trust, dialogue, and relationships across research communities and regions.

China Science Daily: History Museum

As part of the visit, I was given a tour of their History Museum, which offers a thorough perspective on the evolution of China’s first science and technology newspaper, established in 1959. The exhibition highlights how the organization developed into a trusted institution connecting research with the public and policymakers. It was a helpful reminder that at the core of publishing is stewardship, credibility, and long-term public engagement with science.

An Open Exchange on Open Science

During the visit, I met with Dr. Zhao Yan, Editor-in-Chief of ScienceNet. We had an open and engaging conversation about MDPI’s role in Open Access, the evolution of open science globally, and the potential for more collaboration going forward. He especially appreciated the candid and personal nature of our exchange, noting that this kind of dialogue feels important in a landscape where trust and transparency matter.

Interview on Open Access

I also participated in an interview with Ms. Yan Jie, from the Online Media Center and Editor-in-Chief of ScienceNet, China Science Daily. Our discussion covered the growth of Open Access over the past 30 years, MDPI’s mission and values, academic integrity, collaboration with the Chinese research community, and MDPI’s own 30th anniversary milestone. It was a great opportunity to reflect on how open science has matured, and where shared responsibility across publishers, institutions, and researchers continues to matter most.

“Progress in open science is built by more than scale and infrastructure”

I’m sharing a few photos from the visit as a glimpse behind the scenes. The full interview will be published by China Science Daily in due course, and I look forward to sharing it when it is available.

More broadly, visits like this reinforce something I’ve always believed in: progress in open science is built not only through scale and infrastructure, but also through continued dialogue, mutual respect, collaboration, and a willingness to listen across regions and perspectives. That remains central to our work, especially as MDPI reflects on 30 years of publishing, built together.

Inside MDPI

Bangkok Visit: Growth, Partnership, and Local Impact

In February, I also had the opportunity to visit our Bangkok office for the second time in two years to support their local meetings and deliver a training session on how we present MDPI at a corporate level.

It’s easy to spend time with our colleagues in Thailand. From Editorial and Production to Conferences, Marketing, Design, and our Regional Journal Relations Specialist (RJRS), the team continues to grow in scale and professionalism. I’d also like to recognize our local management and admin teams, who have been steadily expanding our office and supporting more than 500 colleagues on the ground.

Academic Partnerships

During the visit, we met with the Engineering Department at King Mongkut’s Institute of Technology Ladkrabang (KMITL). Our discussion focused on the recent MDPI developments, Institutional Open Access Program (IOAP) opportunities, Author Publishing Workshops (APW), and the potential use of JAMS to support their institutional journal.

“MDPI is the third-largest OA publisher in Thailand”

We also shared insights into the growth of Open Access (OA) in Thailand and KMITL’s own publishing trends. These conversations matter because institutions are looking for sustainable ways to support their researchers. Our IOAP agreements are one simple example of how we can provide value in this area while maintaining accessibility for authors.

Thailand and MDPI: 2025 Snapshot

Our Bangkok office, officially launched in 2022, has been growing to support over 500 staff members while continuing to expand its engagement in scholar visits, workshops, and conference collaborations. As at 2025, Thailand submissions to MDPI have increased about 21% and publications by about 25%, maintaining a rejection rate close to the company average. MDPI is the third-largest OA publisher in Thailand, publishing 15% of all Gold OA output in 2025.

Representing MDPI Externally

During the visit, I delivered a training session on how we present MDPI at external events.

This session covered topics related to:

  • Our aim and guiding principles
  • High-level company milestones and Indexing facts and figures
  • Industry partnerships and collaborations
  • Market trends in OA and subscription publishing
  • Country-specific publishing data and collaborations with MDPI
  • Insights from our Voice of Community report

I find that while many colleagues are very familiar with the specific journal for which they have responsibility, fewer have visibility into the broader MDPI ecosystem and the company’s global positioning. These sessions help build alignment, confidence, and consistency in how we represent the company.

What stands out most is that MDPI’s growth is not abstract: it’s visible in the people, the partnerships, and the professionalism developing across our offices.

Coming Together for Science

1,000 Institutional Partners: A Milestone Built on Trust

This month, we reached an important milestone: more than 1,000 institutions worldwide are now part of MDPI’s Institutional Open Access Program (IOAP). On paper, that is a number. In practice, it represents trust.

This milestone symbolizes thousands of conversations with libraries and institutions. It stands for negotiations, renewals, consortium expansions, and, most importantly, relationships built over time. It reflects the work of colleagues across publishing, institutional partnerships, marketing, editorial, finance, and many other teams who contribute to making these agreements operational.

In 2025 alone, more than 61,300 research articles benefited from article processing charge (APC) discounts through IOAP agreements. Tens of thousands of authors were able to publish through a simplified and structured process. At the same time, institutional administrators gained clearer oversight and streamlined workflows.

Why IOAP Matters

When we launched IOAP, the objective was straightforward: to reduce barriers for researchers while supporting institutions in navigating the evolving OA landscape. Over the past decade, the research ecosystem has changed. Funder mandates, national policies, and Plan S–aligned requirements have accelerated the transition to OA.

Institutions need publishing partners who provide transparency, scalability, and operational efficiency. IOAP was designed to support that reality.

For colleagues who would like to better understand the program, this blog-post overview of MDPI’s IOAP provides additional context, including common questions around the transition to OA and how our institutional partnerships are structured.

“Institutions need publishing partners who provide transparency, scalability, and operational efficiency”

Recent Examples

Our agreements continue to evolve across regions:

These examples show that institutions seek structured, predictable models that support their researchers at scale.

Looking Ahead

Crossing the threshold of 1,000 partners tells us that institutions see MDPI not just as a publisher but as a reliable operational partner in advancing open science. This milestone is not a finish line. It is a reminder that the work continues.

Thank you to the entire IOAP team and to all colleagues who contributed to reaching this achievement.

P.S. You can read about this milestone across industry outlets, including STM Publishing News, ALPSP, Research Information, EurekAlert, Brightsurf, among others. You can also read about the coverage in Poland (e.g., media-room, bomega) Korea (newstap), and Romania (EduLike).

Closing Thoughts

Reflections from the Researcher to Reader Conference

During 24–25 February, I attended the 2026 Researcher to Reader Conference in London, UK. Leaders from across scholarly publishing, research infrastructure, libraries, and technology gathered to discuss AI and research integrity, peer review reform, metadata and infrastructure, community engagement, open research policy, and the evolving role of publishers in a rapidly shifting ecosystem.

The conversations were open and honest, and at times uncomfortable – exactly what we need at times. Below are a few reflections that stayed with me.

The Battle for Knowledge: What Becomes Accepted as ‘True’?

One recurring theme was not whether science evolves but whether our infrastructure is resilient enough to sustain trust at scale. Science does not promise certainty: it promises process. As publishing systems grow more complex and become more technologically mediated, the question is how intentionally we design, monitor, and strengthen that process.

Peer Review: Speed, Credentials, and Structural Loops

Researchers consistently call for faster peer review. At the same time, reviewer credentials are often tied to publication records. This creates a structural loop. Publishing history opens reviewing opportunities, reviewing strengthens credentials, and those without early access remain outside the cycle.

There is a need for us to reflect on how opportunity circulates within our systems: we should ask how we create more inclusive pathways for researchers globally to participate in peer review.

Community Engagement Workshop

One of the highlights of R2R was the workshop format, whereby small groups met repeatedly over two days and moved from ideas to tangible strategies.

I joined the Community Engagement workshop led by Lou Peck (CEO at The International Bunch) and Godwyns Onwuchekwa (Principal Consultant at Global Tapestry Consulting). We explored two deceptively simple questions: What is a community? and What does engagement truly mean?

“Engagement requires shared design and shared responsibility”

Too often, organizations equate communication with engagement. The framework discussed mapped a maturity spectrum – from enablement (broadcasting, informing and consulting) to true engagement (collaborating and co-creating).

It was a useful reminder of the fact that if we want trust and loyalty, engagement must go beyond announcements and surveys. It requires shared design and shared responsibility.

AI: Democratization or Digital Colonialism?

I especially enjoyed the thought-provoking presentation from Nikesh Gosalia (Chief Partnership Officer at Cactus Communications), which highlighted an uncomfortable reality:

  • 93% of AI-generated content is in English
  • Approximately 2% is in French
  • Approximately 2% is in German
  • More than 7,000 languages are represented in less than 5% of the content within large AI systems

The implications are profound. Is AI democratizing access to scholarly publishing (making it easier for researchers everywhere to participate in global knowledge production)? Or are we encoding colonialism at scale (entrenching linguistic and structural hierarchies, and making it harder for voices from the Global South to be heard)?

AI is already reshaping how research is created, reviewed, discovered, and shared. Its potential is enormous. But its impact depends not only on capability, but on governance, design, and intentionality. Publishers, funders, and researchers all share responsibility in shaping how these systems evolve.

Ethicality in practice (Lightening Talk)

It was also great to have our colleague Dr Miloš Čučulović (Head of Technology Innovation at MDPI) present MDPI’s Ethicality platform during a lightning talk.

“Technology alone is not the answer”

Ethicality embeds AI-driven checks directly into the submission workflow, supporting editors proactively rather than reacting after publication. As we scale, tools like this help balance trust, efficiency, and research integrity.

This goes back into the underlying theme of the conference that technology alone is not the answer. However, technology embedded thoughtfully within clear governance frameworks can strengthen confidence in the editorial process.

Final thought

The question is no longer whether technology will transform research infrastructure: it is already doing so. The real question is what role each of us will play in shaping that transformation deliberately, with structural maturity, inclusive governance, and engagement that moves from informing to co-creating.

Science needs to evolve, responsibly. And that responsibility extends not only to what we publish, but also to how the systems behind publication are designed. Some important topics to continue reflecting on both internally and within our broader community.

Stefan Tochev
Chief Executive Officer
MDPI AG

20 February 2026
MDPI Virtual Academic Publishing Workshop (New Harvest), 25 February 2026


This Academic Publishing Workshop will be led by MDPI Regional Journal Relations Specialist, Dr. Sally Wu, on “Author Training”. Participants will receive practical advice on essential aspects of writing academic articles. Participants will leave with a clearer understanding of the academic publishing landscape and how to successfully contribute to it.

Date: 25 February 2026
Time: 11:30 a.m.–1:30 p.m. EST

Schedule:

Speaker

Program

Time in EST

Dr. Sally Wu

Introduction

11:30–11:40 a.m.

Dr. Sally Wu

Tips for Writing Great Research Papers

  • Structuring a research paper
  • Tips for every section of a research paper
  • Q&A Session

11:40 a.m.–12:15 p.m.

Dr. Sally Wu

How to Respond to Peer Reviewers

  • Peer Review Reports
  • Examples of Response to Reviewers
  • Q&A Session

12:15–12:50 p.m.

Dr. Sally Wu

AI in Publishing: Challenges and Opportunities

  • AI in scientific publishing
  • How to use AI ethically
  • Q&A Session

12:50–13:30 p.m.

Speakers:

Dr. Sally Wu received a PhD in medical science from the University of Toronto in the fall of 2025. She joined MDPI in February 2025 as an Assistant Editor for Cells. She was recently promoted to Regional Journal Relations Specialist position in August. In this role, she works with many journals, liaising with authors, board members, and EiCs. She has attended several conferences across North America, hosted scholar visits, and taken part in other outreach events.

18 February 2026
MDPI’s Open Access Program Reaches 1,000 Institutions Worldwide

MDPI has surpassed the milestone of 1,000 partners within the Institutional Open Access Program (IOAP). The agreements span 59 countries, covering North and South America, Europe, Asia, Africa, and Oceania.

Last year alone, more than 150 new libraries and academic institutions joined MDPI’s IOAP. With the expansion of an existing consortium deal in Sweden we welcomed a further 75 partners to the program in January 2026, enabling us to surpass the 1,000-partners milestone.

The IOAP supports affiliated researchers by streamlining submission processes, reducing administrative burdens, and offering discounted Article Processing Charges (APCs). Through IOAP membership, more than 61,300 research articles received APC discounts in 2025, driving greater visibility and accessibility for partner institutions and global research communities alike.

"This milestone marks a significant step towards expanding MDPI’s global impact," said Stefan Tochev, MDPI's CEO. "Reaching 1,000 IOAP partnerships is a true testament to the growing trust and collaboration we’ve built with universities, libraries, and research organizations worldwide. We are proud to lead the way in Open Access publishing, ensuring researchers have the support they need to reach global audiences." "The success of our program is reflected in the growing global demand for Open Science and quality publishing services," said Becky Castellon, MDPI institutional partnerships manager. "Equally, institutions are increasingly seeking Open Access publishing options that support funder and national mandates. Joining the IOAP makes compliance simple."

12 February 2026
Current Oncology | Special Issue “Evolution of Treatments of Prostate Cancer” Reprint

We are delighted to share with you a reprint of the Special Issue published in January 2026 in Current Oncology (ISSN: 1718-7729), comprising 9 articles. You can access more Current Oncology Special Issue reprints at the following link: https://www.mdpi.com/books/search.

“Evolution of Treatments of Prostate Cancer: From Biology to Current Advanced Technologies”
Edited by Dr. Fernando Munoz

ISBN 978-3-7258-6065-4 (Hardback)
ISBN 978-3-7258-6066-1 (PDF)

https://doi.org/10.3390/books978-3-7258-6066-1

Available online here: https://www.mdpi.com/books/reprint/12149-evolution-of-treatments-of-prostate-cancer.

If you are interested in editing a Special Issue, please apply here: https://www.mdpi.com/journalproposal/sendproposalspecialissue/curroncol.

11 February 2026
MDPI Webinar | World Cancer Day, 12 February 2026


To commemorate World Cancer Day 2026, MDPI is delighted to introduce the “World Cancer Day 2026 Webinar Series”. Reflecting the global theme “United by Unique,” this series reminds us that each story, discovery, and voice plays a vital role in strengthening the world’s collective fight against cancer.

Kicking off with our February session, this first installment welcomes leading voices in oncology to share impactful insights, raise awareness, and spotlight breakthrough research.

Through this series, we aim to empower the global community with knowledge, inspire collaboration, and support ongoing efforts in cancer prevention, diagnosis, and treatment.

Together, we will honor every patient’s journey, elevate the contributions of researchers, and reinforce the power of collective action in the fight against cancer.

Date: 12 February 2026
Time: 6:00 p.m. CET | 12:00 p.m. EST | 1:00 a.m. CST (Asia)
Webinar ID: 899 8080 6135
Webinar Secretariat: journal.webinar@mdpi.com

Register now for free!

Program:

Speaker and Presentation Title Time in CET Time in EST
Introduction 6:00–6:10 p.m. 12:00–12:10 p.m.
Dr. Xiang Xue
PINK1 Deficiency Facilitates Mitochondrial Iron Accumulation and Colon Tumorigenesis
6:10–6:30 p.m. 12:10–12:30 p.m.
Dr. Federico Pio Fabrizio
Epigenetics of KEAP1/NRF2 Signaling: From Molecular Mechanisms to Clinical Implications
6:30–6:50 p.m. 12:30–12:50 p.m.
Dr. Anis Ahmad
Protecting Healthy Organs While Treating Cancer: New Molecular Strategies to Improve Survivorship
6:50–7:10 p.m. 12:50–1:10 p.m.
Dr. Hiroaki Kiyokawa
Stabilizing Tumor Suppressors: Therapeutic Frontiers in Precision Medicine
7:10–7:30 p.m. 1:10–1:30 p.m.
Q&A Session 7:30–7:55 p.m. 1:30–1:55 p.m.
Closing of Webinar 7:55–8:00 p.m. 1:55–2:00 p.m.

After registering, you will receive a confirmation email on how to join the webinar. Registrations with academic institutional email addresses will be prioritized.

Unable to attend? Register anyway, and we will let you know when the recording is available for viewing.

Webinar Keynote Speakers:

  • Dr. Xiang Xue, Department of Biochemistry and Molecular Biology, School of Medicine, University of New Mexico, USA;
  • Dr. Federico Pio Fabrizio, Department of Medicine and Surgery, Faculty of Medicine, Kore University of Enna, Italy;
  • Dr. Anis Ahmad, Department of Radiation Oncology, Miller School of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, USA;
  • Dr. Hiroaki Kiyokawa, Department of Pharmacology, Feinberg School of Medicine, Northwestern University, USA.

5 February 2026
Acknowledgment to the Reviewers of Current Oncology in 2025


The editorial office of Current Oncology would like to extend its sincere gratitude to all reviewers who contributed to the improvement of the journal quality by providing their expert opinion and evaluation of the submitted research.

We appreciate that thorough peer review demands considerable time and intellectual investment from our reviewers. In 2025, Current Oncology received 3316 review reports from contributors across 69 countries and territories, demonstrating the breadth of international expertise and scholarly engagement that has strengthened our publication standards.

The reviewers who agreed to have their names published this year are listed below in alphabetical order by first name. The editorial team acknowledges with gratitude all reviewers, named and anonymous alike, for their vital role in maintaining the scholarly standards of Current Oncology.

Abdallah Y. Naser Kirstin Perdrizet
Abdullah Mohammad Khan Kleoniki Roka
Abdulqadir J. Nashwan Koki Nakanishi
Abdurraouf Mokhtar Mahmoud Konstantinos Giakoumidakis
Abhisek Ghosal Konstantinos Seretis
Abhishek Kumar Kozo Kuribayashi
Adam Grzegorz Michalski Laila Hubbert
Agnieszka Bojarska-Junak Lan Lin
Akash Sabarwal Lana Kovač Bilić
Alberto Arezzo Leonardo Garutti
Alberto Bongiovanni Lesley Storey
Albrecht Piiper Lin Song Kretschmer
Aldona Kasprzak Lionel F. Gamarra
Alessandro Gonfiotti Liton Devanth
Alessandro Ottaiano Lorenzo Magrassi
Alexander J. Bankovich Luca Flesia
Alexandros Laios Lucía Ortiz-Comino
Alexis Murillo Carrasco Lucy Bregman
Ali Golestani Madelon Dijkstra
Ali Khodadadi Madhusudan Prasad Koya
Alice Nicoleta Drăgoescu Maged T. El-Ghannam
Althaf Shaik Mai M. El-Daly
Ameen A. Abu-Hashem Maitane Asensio
Amélia Ferreira Małgorzata Blatkiewicz
Ana Jotic Malgorzata Gorczak
Ana M. Mota Małgorzata Klimek
Anastasios Apostolos Manjari Kundu
Anastasios J. Karayiannakis Manlio Ferrarini
Andrea Ambrosini-Spaltro Manon Lemonde
Andrea Espejo-Freire Mansoor-Ali Vaali-Mohammed
Andrea Piasentin Manuel M. Pérez-Encinas
Andreea Moise-Crintea Manuel Vaz-da-Silva
Andrew Yeudall Marco de Scordilli
Andrzej Kasperski Marcodomenico Mazza
Angelo Naselli Margarida Figueiredo-Dias
Anita Kurilla Maria Anastasiou
Ankush Chandra Maria Kapritsou
Anna Bellizzi Marin Prpic
Anna Furlan Marina Ibragimova
Anna Markowska Markus Blaurock
Anna Siemiątkowska Marta Fudalej
Anna Urbaniak Martin Heidinger
Anthony Kim Martina Arcieri
Antoine Desilets Martina Kleber
Anton Tkachenko Marzia Sichetti
Antonio Andrea Grosso Masaaki Noguchi
Antonio Martinez-Sabater Massimo Bonucci
Antonio Minni Matteo Bruno
Arjan Vissink Matthew Field
Arne Westgaard Mauricio Rodriguez-Dorantes
Arnulfo Hernan Nava-Zavala Maximilian Scheer
Arvind Kumar Shukla Meghana Singh
Arvind Mukundan Melody Devos
Athanasios A. Panagiotopoulos Menelaos Zafrakas
Athanasios Koutras Meng Zhao
Atsuto Katano Merica Glavina Durdov
Bahil Ghanim Michael Paulussen
Bartłomiej Barczyński Michael Schwake
Baudolino Mussa Michaela Cellina
Bernardo Cacho-Díaz Michail Galanis
Bibo Tan Michał Kisielewski
Birendra Kumar Sah Michele Boffano
Božana Lončar Brzak Michelle Nadler
Camelia Alexandra Coada Michiel Wilhelmus Maria van den Brekel
Camillo Fulchignoni Miguel Mendoza-Catalán
Carla Pisani Miha Petric
Cecilia Taverna Mihai Capilna
Chaitanya Gadepalli Mika Mizuno
Charlotte Toftmann Hansen Milena Cavic
Chen Wang Miryam Chiara Malacarne
Cheng Cheng Mita Manna
Chenlong Yang Mohamad Adam Bujang
Chenxi Li Mohamed Ashraf Eltokhy
Chieh-Hsiang Yang Mohammad Mofatteh
Christian Bailly Mohammed Alnaggar
Christina Oetzmann von Sochaczewski Momcilo Jankovic
Claire Link Monica Cappetta
Constantino Ricci Morena Miciaccia
Cosmin Ioan Faur Moumita Chakraborty
Cristina Oprean Muhammed A Moukhtar Hammad
Dae-Gon Ryu Muntean Calin
Daisuke Kyuno Nadia Carminia Espejo Herrera
Daniel Sitar Naonori Kawakubo
Daniele Napolitano Naotake Funamizu
Danuta Januszkiewicz-Lewandowska Natalia Stepanova
Darrell O. Ricke Neil Merrett
Davide Corà Nektarios Koufopoulos
Denis Soulieres Nicholas Bertos
Despoina Pantazi Nicola Magnavita
Dhananjay Singh Nobuaki Kobayashi
Dilinaer Wusiman Norikazu Tanabe
Dimitrios Varvoglis Norman Williams
Dimitrios Zouzoulas Normand García-Hernández
Dinesh Kumar Thekkinkattil Nuha El Sharif
Diwakar Guragain Olga Gordeeva
Dmitriy Viderman Omar Hamdy
Domenico Motola Osama Shiraz Shah
Domenico Prisco Pablo Díaz-Calvillo
Dragoş Mircea Median Paolo Scanagatta
Duvern Ramiah Paolo Spinnato
Edyta Maria Urbanska Paul Thevenot
Eelco de Bree Pedro Silva-Vaz
Elena Chitoran Pei Li
Elena Cojocaru Peter Muscarella
Eleni Mavrogonatou Piercarmine Panzera
Eleonora Pinto Pierluigi Fracasso
Elias Kouroumalis Pierre Tennstedt
Elissavet Anestiadou Pinelopi Samara
Elizabeth C. Penick Pinki Prasad
Emanuela Risi Piotr Mamczur
Emilija Strelcenia Piotr Pawłowski
Enrico Giarnieri Prachi Chavan
Erasmo Barros da Silva, Jr. Prawej Ansari
Erden Atilla Qi Shao
Eric Huet Qingsong Pang
Erika Skrodeniene Radoslaw Pach
Esteban Fuentes-Valenzuela Rafael Ríos-Tamayo
Eva Meixner Raffaella Cerretti
Ewa Błaszczyk-Bębenek Ranjeet Kumar
Fabio Fabbian Raquel Garcia Lopez
Fábio Morato Oliveira Ravi Ramjeesingh
Fabio Vistoli Reza Nedaeinia
Fang Li Riccardo Vecellio Segate
Federico Bozzetti Rima Kregždytė
Felix J. Klimitz Rina Kansal
Feng Yang Rita Cascão
Fernanda Loureiro Rita Oliveira
Florbela Gonçalves Robert Kleszcz
Fowie Ng Rossella Melcarne
Francesca Angelone Ruth Parks
Francesca Mancuso Sabina Sevcikova
Francesca Rossi Saeed Baradwan
Francesco Pio Bizzarri Saikat Chakraborty
Francisco Tustumi Sally Taylor
Franco Alchiede Simonato Salvatore Corallo
François Chevalier Salvatore Gallo
Fuat Demirkíran Salvatore Vaccaro
Gaetano Marverti Sandra Pelaez
George Gourzoulidis Sanne Lof
Georgia Gomatou Sarah J. Allgood
Getinet Adinew Scott Livingstone
Gianluca Piccolo Se An Oh
Giorgio Perino Seamus O’Reilly
Giovanna Ricci Sebastian Valverde-Martinez
Giovanni Mazzucato Semra Ince
Giuliana Ciappina Sen Zhang
Giuseppe Brisinda Seongmin Kim
Giuseppe Facondo Serge Weis
Giuseppe Iatì Shankara Narayanan Varadarajan
Giuseppe Lanzarone Shivang Sunil Parikh
Goran Augustin Shiyang Kang
Gorkem Durak Shuai Ren
Guiping Liu Shuhei Suzuki
Hamid Osman Shuji Ozaki
Hannah M. Fisher Shuntaro Obi
Haowei Tai Sijin Wen
Hathal Haddad Silambarasan Anbumani
Herman J. Woerdenbag Silvia Vanni
Hideki Katayama Silviu Cristian Voinea
Hiroyuki Noda Simona Miceska
Hisham Bahmad Snjezana Cukljek
Hitoshi Maemoto Soo Jin Kim
Hong-Yue Lai Soo-Hyun Sung
Hosein Ameri Sorabh Kapoor
Howard Lopes Ribeiro Junior Spiros Vlahopoulos
Hsiang-Hsuan Michael Yu Stefano Andreoli
Huaifu Deng Steven T. Brower
Husam Qanash Subhash Chandra Sethi
Ilir Agalliu Sung Han Kim
Ina Sevic Sung-Lang Chen
In-Jae Oh Surajit Basak
Ioanna Tsatsou Susana Miguel
Ioannis Katsaros Sveinung Wergeland Sorbye
Iordanis Pelagiadis Sweta Misra
Irena Ilic Szymon Janczar
Isaac Ceballos Lenza Taha Koray Sahin
Isabel Fernandes Taiqiang Yan
Isabel Maria Ribeiro Fernandes Takahiko Murayama
Isao Otsuka Takanori Konishi
Isha Singh Tao Xu
Iwona Malicka Teodora Telecan
Jacopo Crippa Theodoros Karalis
Jacqueline M. Bentel Theodoros Spinos
Jakub Bargiel Theofanis Vavilis
Jakub Kufel Thomas Licht
Jan Bocianowski Thomas Linsenmann
Janaina Fernandes Thomas Peponis
Jarmila Pekarcikova Tianhua Niu
Jasper de Boer Tomas Koltai
Jeffery Smith Tomohiro Chiba
Jelena Jovičić-Bata Tomoyuki Araya
Jelena Roganovic Torben Redmer
Jennifer Davis Toshifumi Hara
Jennifer Haynes Venkatraman Pitchaikannu
Jenny Drott Vikas Kumar Somani
Jesika S. Faridi Vimoj Janardanan Nair
Jimmy Thomas Efird Vincenza Gianfredi
Jincheng Wang Vineel Bhatlapenumarthi
Jing Xu Virginia Pistone-Creydt
Jingcheng Zhou Vivek Bhadri
Jingwei Zhang Vlad Horia Schitcu
Jiri Remr Vlad Rotaru
Joaquim Soares do Brito Vladimir Bilim
Johannes Naumann Vladimir Poroch
John Amson Capitman Vladimir Rogalewicz
John S. Mitchell Wai Chin Chong
Joonho Moon Wankyu Eo
José Antonio de Paz Weijie Ma
Juan S. Izquierdo-Condoy Weiren Luo
Juan Torres Melero Wilhelm Mosgoeller
Julia Hentschel Xiaodong Wang
Junbiao Wang Yasushi Kubota
Jung Ho Park Yi-Cheng Wu
Ju-Seop Kang Yijun Mei
Kajetan Kiełbowski Yoichi Watanabe
Karan Jatwani Yoshiaki Yura
Kasturi Bala Nayak Yoshihiro Nabeya
Katie Devine Yousef Tanas
Katrin Welcker Yuan Chai
Katsuaki Ieguchi Yudai Ishiyama
Katsushi Takebayashi Yuhao Xie
Katsuya Kitamura Yuliya Semenova
Kazim Arga Yunfeng Dai
Kazuo Kobayashi Zengjie Ye
Keisuke Ishizawa Ziqing Chen
Keita Kai Zoltan Herold
Kevinn Eddy Zoltán Mátrai
Khoja Leila  

3 February 2026
World Cancer Day—“United by Unique”, 4 February 2026


World Cancer Day draws global attention to the ongoing fight against cancer—one of the leading causes of morbidity and mortality worldwide. Observed annually on 4 February, World Cancer Day unites individuals, communities, researchers, clinicians, and policymakers in a shared commitment to reduce the global cancer burden and improve outcomes for patients everywhere.

Aligned with this year’s theme and the United Nations Sustainable Development Goal 3 (Good Health and Well-Being), the initiative calls for greater awareness, early detection, equitable access to care, and sustained investment in cancer research and innovation. From prevention and diagnosis to treatment and survivorship, addressing cancer requires coordinated, multidisciplinary efforts across healthcare systems and scientific communities worldwide.

In support of World Cancer Day, selected MDPI journals highlight cutting-edge research across the cancer continuum, including advances in oncology, diagnostics, therapeutics, public health, and patient-centred care. Through curated articles, Special Issues, and expert-led webinars, these journals aim to foster knowledge exchange and collaboration to accelerate progress toward a future where cancer prevention and treatment are accessible, effective, and equitable for all.

In 2026, MDPI is honored to support World Cancer Day through a monthly awareness ries beginning in February. Each session will focus on a key cancer awareness theme, showcasing cutting-edge research and expert insights through specially curated landing pages and a dedicated webinar series. Through this special activity, we aim to sustain engagement and cross-disciplinary collaboration throughout the year. Below is the list of events. You may click on the respective links (updated throughout the year, closer to each event month) to access the individual event pages.

Month Relevant Cancer Awareness Month
January Cervical Cancer Awareness Month
February National Cancer Prevention Month
March Colorectal Cancer Awareness Month
April Esophageal Cancer Awareness Month
May Bladder Cancer Awareness Month
June Cancer Survivorship Awareness Month
July Sarcoma and Bone Cancer Awareness Month
August Brain Cancer Awareness Month
September Childhood Cancer Awareness Month
October Breast Cancer Awareness Month
November Lung Cancer Awareness Month
December Skin Cancer Awareness Month


Keynote Speakers

Dr. Xiang Xue,
University of New Mexico, USA

Dr. Federico Pio Fabrizio,
Kore University of Enna, Italy

Dr. Anis Ahmad,
University of Miami, USA

Dr. Hiroaki Kiyokawa,
Northwestern University, USA

Register for this webinar for free here!

 

Molecular Insight and Antioxidative Therapeutic Potentials of Plant-Derived Compounds in Breast Cancer Treatment
by Sandhya Shukla, Arvind Kumar Shukla, Adarsha Mahendra Upadhyay, Navin Ray, Fowzul Islam Fahad, Arulkumar Nagappan, Sayan Deb Dutta and Raj Kumar Mongre
Onco 2025, 5(2), 27; https://doi.org/10.3390/onco5020027

Comprehensive Analysis of Advancement in Optical Biosensing Techniques for Early Detection of Cancerous Cells
by Ayushman Ramola, Amit Kumar Shakya and Arik Bergman
Biosensors 2025, 15(5), 292; https://doi.org/10.3390/bios15050292

Advancing Cancer Treatment: A Review of Immune Checkpoint Inhibitors and Combination Strategies
by Valencia Mc Neil and Seung Won Lee
Cancers 2025, 17(9), 1408; https://doi.org/10.3390/cancers17091408

Prunin: An Emerging Anticancer Flavonoid
by Juie Nahushkumar Rana and Sohail Mumtaz
Int. J. Mol. Sci. 2025, 26(6), 2678; https://doi.org/10.3390/ijms26062678

Advancing Cancer Therapy with Quantum Dots and Other Nanostructures: A Review of Drug Delivery Innovations, Applications, and Challenges
by Ashutosh Pareek, Deepanjali Kumar, Aaushi Pareek and Madan Mohan Gupta
Cancers 2025, 17(5), 878; https://doi.org/10.3390/cancers17050878

From Bench to Bedside: Transforming Cancer Therapy with Protease Inhibitors
by Alireza Shoari
Targets 2025, 3(1), 8; https://doi.org/10.3390/targets3010008

Breast Cancer and Tumor Microenvironment: The Crucial Role of Immune Cells
by Tânia Moura, Paula Laranjeira, Olga Caramelo, Ana M. Gil and Artur Paiva
Curr. Oncol. 2025, 32(3), 143; https://doi.org/10.3390/curroncol32030143

Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer
by Jennifer Haynes and Prasath Manogaran
Int. J. Mol. Sci. 2025, 26(5), 1988; https://doi.org/10.3390/ijms26051988

Polyphenol-Based Prevention and Treatment of Cancer Through Epigenetic and Combinatorial Mechanisms
by Neha Singaravelan and Trygve O. Tollefsbol
Nutrients 2025, 17(4), 616; https://doi.org/10.3390/nu17040616

Advances in Drug Targeting, Drug Delivery, and Nanotechnology Applications: Therapeutic Significance in Cancer Treatment
by Fatih Ciftci, Ali Can Özarslan, İmran Cagri Kantarci, Aslihan Yelkenci, Ozlem Tavukcuoglu and Mansour Ghorbanpour
Pharmaceutics 2025, 17(1), 121; https://doi.org/10.3390/pharmaceutics17010121

 

Genetic and Epigenetic Analyses in Cancer
Guest Editor: Prof. Dr. Jing Gong
Deadline for manuscript submissions: 20 April 2026

Improving the Quality of Life in Patients with Gynecological Cancer
Guest Editor: Dr. Vasilios Pergialiotis
Deadline for manuscript submissions: 20 May 2026

Antibody-Mediated Therapy and Other Emerging Therapies in Cancer Treatment
Topic Editors: Dr. Won Sup Lee, Prof. Dr. Yaewon Yang and Prof. Dr. Seil Go
Deadline for manuscript submissions: 31 July 2026

Advances in Implementation Science and Knowledge Mobilization for Cancer Control
Guest Editor: Dr. Sarah Neil-Sztramko
Deadline for manuscript submissions: 31 August 2026

Back to TopTop